• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.14% Nasdaq Down 0.35%

    More On BNIKF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Benitec Biopharma Limited (BNIKF)

    -Other OTC
    0.36 Down 0.01(3.23%) Sep 3, 2:07PM EDT
    Add to Portfolio
    Prev Close:0.37
    Open:0.36
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.36 - 0.36
    52wk Range:0.32 - 0.99
    Volume:35,469
    Avg Vol (3m):36,656
    Market Cap:41.72M
    P/E (ttm):N/A
    EPS (ttm):-0.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):33.38
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Benitec Biopharma Limited, a biotechnology company, develops treatments for chronic and life-threatening human diseases based on its gene silencing technology, DNA-directed RNA interference (ddRNAi) in Australia. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback